Study reveals key pathway for immune cell migration in atherosclerosis
CD8+ T cells accumulate in atherosclerotic plaques. LMU researchers identify a crucial signaling pathway—with therapeutic ...
News Medical on MSN4 小时
Atherosclerosis: how immune cells migrate into plaques
CD8+ T cells accumulate in atherosclerotic plaques. LMU researchers identify a crucial signaling pathway – with therapeutic potential.
ahajournals.org15 天
Lipoprotein(a) as a Pharmacological Target: Premises, Promises, and Prospects
Atherosclerotic cardiovascular disease is a major health concern worldwide and requires effective preventive measures. Lp(a) (lipoprotein [a]) has recently garnered attention as an independent risk ...
News Medical on MSN12 天
KLX mitigates atherosclerotic progression by preventing EndMT
Atherosclerosis, a disease characterized by the accumulation of lipids and inflammatory cells in the arterial wall, is a ...
emjreviews.com6 天
OCEAN(a)-DOSE Trial: New Data on Lipoprotein(a) and Oxidized Phospholipids
Olpasiran reduces oxidized phospholipids but not inflammation in cardiovascular disease—what does this mean for clinical care ...
Hiker's death at Punch Bowls area outside Santa Paula attributed to drowning
A hiker who died Sunday at the Punch Bowls area near Santa Paula has been identified. The 44-year-old Oxnard man was identified Monday as John Antonio Madrigal by the Ventura County Medical Examiner's ...
Veru Reports Fiscal 2025 First Quarter Financial Results and Clinical Program Progress
Company reported positive Phase 2b QUALITY study topline results for enobosarm + semaglutide (Wegovy®) with study meeting prespecified primary ...
Veru targets Phase 3 enobosarm trials following promising Phase 2b results in obesity treatment
Discover Veru Inc.'s latest Q1 2025 updates on enobosarm & sabizabulin trials, financials, & strategic pivots in cardiometabolic and inflammation treatment.